Edward Wang

Dr. Wang has 25+ years of research experience and has in-depth knowledge of biopharmaceutical research and the IND and NDA processes. Prior to joining the Group, Dr. Wang served as the deputy general manager at Shanghai Furen Medicine R&D Co., Ltd. from October 2016 to June 2018 and the director of vaccine production in Newlink Genetics Inc., for a special project to fight the Ebola Epidemic from August 2014 to June 2016. In our Group, Dr. Wang leads the teams focused on manufacturing and regulatory compliance.